Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance

scientific article

Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/neuroimage/ScarmeasHZAPHPT04
P356DOI10.1016/J.NEUROIMAGE.2004.04.032
P932PMC publication ID3026571
P698PubMed publication ID15325350
P5875ResearchGate publication ID8387470

P50authorDavangere DevanandQ5228136
Nikolaos ScarmeasQ64856639
James R. MoellerQ67409205
Gregory H PeltonQ86681358
Christian HabeckQ90634919
Eric ZarahnQ114430616
Matthias H TabertQ117251738
Aileen ParkQ117251739
Yaakov SternQ46943072
P2093author name stringLawrence S Honig
Karen E Anderson
John Hilton
P2860cites workA default mode of brain functionQ24544311
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
Neuropathological stageing of Alzheimer-related changesQ27860862
Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's diseaseQ29030074
Modality-specific retrograde amnesia of fearQ29618419
Functional networks in motor sequence learning: abnormal topographies in Parkinson's diseaseQ30631959
The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerationsQ30632825
Functional deactivations: Change with age and dementia of the Alzheimer typeQ33718158
Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regionsQ33975597
Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.Q34244667
Positron emission tomography in patients with clinically diagnosed Alzheimer's diseaseQ34727718
Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic dataQ36460668
Network analysis of brain cognitive function using metabolic and blood flow dataQ36704081
Functional connectivity: the principal-component analysis of large (PET) data setsQ36774679
Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI.Q36887725
ATP and brain functionQ38597443
Voxel-based mapping of brain hypometabolism in permanent amnesia with PET.Q39171908
Functional deficits in patients with mild cognitive impairment: prediction of AD.Q40654211
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairmentQ40716303
Preclinical prediction of Alzheimer's disease using SPECT.Q40854656
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's DiseaseQ42470207
Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's diseaseQ57700615
Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at restQ68691950
The metabolic topography of idiopathic torsion dystoniaQ70987276
Cerebral metabolic topography in unilateral temporal lobe epilepsyQ71631162
Restriction isotyping of human apolipoprotein A-IV: rapid typing of known isoforms and detection of a new isoform that deletes a conserved repeatQ42614763
The metabolic topography of normal agingQ42629288
Hippocampal formation glucose metabolism and volume losses in MCI and AD.Q43668221
Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolismQ43679905
Metabolic changes following subthalamotomy for advanced Parkinson's diseaseQ43767019
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcomeQ43788870
Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.Q43790732
Metabolic correlates of levodopa response in Parkinson's diseaseQ43820136
Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's DiseaseQ43899469
Brain glucose hypometabolism after perirhinal lesions in baboons: implications for Alzheimer disease and agingQ44170858
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.Q44249033
Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implicationsQ44580118
Functional imaging of the monkey brainQ48134538
Brain SPECT imaging and left hemispatial neglect covaried using partial least squares: the Sunnybrook Stroke studyQ48160521
Dementia: the estimation of premorbid intelligence levels using the New Adult Reading TestQ48184614
Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's diseaseQ48254234
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's diseaseQ48259581
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's diseaseQ48271491
Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mappingQ48299499
Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation.Q48326760
Functional brain networks in DYT1 dystoniaQ48389410
Altered glucose metabolism in the hippocampal head in memory impairmentQ48425138
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's diseaseQ48671019
Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomographyQ48701304
The metabolic topography of essential blepharospasm: a focal dystonia with general implicationsQ48714455
Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer's diseaseQ48853089
The primate hippocampal formation: evidence for a time-limited role in memory storageQ48879853
The relationship between global and local changes in PET scansQ48940829
Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's diseaseQ49045185
18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scansQ49112405
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.Q51183354
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.Q51974478
Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease.Q52020527
FDG PET imaging in patients with pathologically verified dementia.Q52023258
Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease.Q52026612
Normalizing counts and cerebral blood flow intensity in functional imaging studies of the human brain.Q52047670
Spatial pattern analysis of functional brain images using partial least squares.Q52047671
Evaluating storage, retention, and retrieval in disordered memory and learningQ52115465
Neuropsychological investigation of memory, visuoconstructional, visuoperceptual, and language abilities in senile dementia of the Alzheimer type.Q52217675
A new clinical scale for the staging of dementia.Q52220854
Combining spatial extent and peak intensity to test for activations in functional imaging.Q52275212
Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease.Q52520990
Pathological and positron emission tomographic correlations in Alzheimer's disease.Q53189657
Network analysis of PET-mapped visual pathways in Alzheimer type dementia.Q53212837
Different brain networks mediate task performance in normal aging and AD: defining compensation.Q53239067
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.Q54159517
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
dementiaQ83030
cognitive dysfunctionQ57859955
P304page(s)35-45
P577publication date2004-09-01
P1433published inNeuroImageQ1981225
P1476titleCovariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance
P478volume23

Reverse relations

cites work (P2860)
Q37371552A spatial covariance (123)I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease.
Q46815002Abnormal metabolic networks in atypical parkinsonism
Q37149923An investigation of statistical power for continuous arterial spin labeling imaging at 1.5 T.
Q35018093Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease
Q37046003Aspects of Attention Predict Real-World Task Performance in Alzheimer's Disease
Q33650839Basics of Multivariate Analysis in Neuroimaging Data
Q49787280Cerebral Perfusion Insufficiency and Relationships with Cognitive Deficits in Alzheimer's Disease: A Multiparametric Neuroimaging Study
Q38747398Cerebral metabolic changes related to clinical parameters in idiopathic anosmic patients during olfactory stimulation: a pilot investigation
Q42019841Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners
Q35103247Cognitive reserve in aging.
Q90650252Cognitive reserve-mediated neural modulation of emotional control and regulation in people with late-life depression
Q61808429Comparison of Count Normalization Methods for Statistical Parametric Mapping Analysis Using a Digital Brain Phantom Obtained from Fluorodeoxyglucose-positron Emission Tomography
Q48371182Covariance 99mTc-exametazime SPECT patterns in Alzheimer's disease and dementia with Lewy bodies: utility in differential diagnosis
Q61887965Covariance statistics and network analysis of brain PET imaging studies
Q51097291Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia.
Q39318829Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases
Q33497053Examining the multifactorial nature of cognitive aging with covariance analysis of positron emission tomography data
Q33347622Experience and perspectives of caregivers of spouse with mild cognitive impairment
Q91787044Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT)
Q36749923Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease
Q34727381Hierarchical multivariate covariance analysis of metabolic connectivity
Q37176128Hippocampal hyperperfusion in Alzheimer's disease
Q35799867Involvement of Subcortical Brain Structures During Olfactory Stimulation in Multiple Chemical Sensitivity
Q33821620Long term caregiving: helping families of persons with mild cognitive impairment cope
Q36942803Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?
Q35684482Metabolic brain networks associated with cognitive function in Parkinson's disease
Q33504970Metabolic brain networks in neurodegenerative disorders: a functional imaging approach
Q37262851Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease
Q36739358Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease
Q36745127Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis
Q36579113Neural network approaches and their reproducibility in the study of verbal working memory and Alzheimer's disease
Q28744562New computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping method
Q48693125PET network abnormalities and cognitive decline in patients with mild cognitive impairment
Q34121338Partial least squares for discrimination in fMRI data
Q33224917Pathology of the insular cortex in Alzheimer disease depends on cortical architecture
Q37298543Preserved frontal memorial processing for pictures in patients with mild cognitive impairment.
Q46467732Principal component analysis of FDG PET in amnestic MCI.
Q33720955Regional Cerebral Blood Flow in Mild Cognitive Impairment and Alzheimer's Disease Measured with Arterial Spin Labeling Magnetic Resonance Imaging
Q48103246Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.
Q34092951Relating education, brain structure, and cognition: the role of cardiovascular disease risk factors
Q50586795Spinal Alterations of Reil Insula in Alzheimer's Disease.
Q36853915Strategies for molecular imaging dementia and neurodegenerative diseases
Q31152078Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study
Q34007166Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease
Q35050081Volumetric correlates of spatiotemporal working and recognition memory impairment in aged rhesus monkeys

Search more.